The High Expression of Key Components of Inflammasome and Pyroptosis Might Lead to Severe COVID-19 Infection in Cancer Patients
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
SARS-CoV-2 variant-dependent inflammasome activation.
Teyssou E, Marot S, Gothland A, Malet I, Zafilaza K, Leducq V J Infect. 2023; 87(1):62-63.
PMID: 37060923 PMC: 10101480. DOI: 10.1016/j.jinf.2023.04.005.
Meng R, Zhang N, Yang F, Xu Z, Wu Z, Du Y J Infect. 2023; 86(4):e104-e106.
PMID: 36775249 PMC: 9916182. DOI: 10.1016/j.jinf.2023.02.011.
References
1.
Ma J, Yin J, Qian Y, Wu Y
. Clinical characteristics and prognosis in cancer patients with COVID-19: A single center's retrospective study. J Infect. 2020; 81(2):318-356.
PMC: 7194544.
DOI: 10.1016/j.jinf.2020.04.006.
View
2.
Qin G, Yang J, Zhao C, Ren J, Qu X
. The COVID-19 susceptibility of cancer patients might due to the high expression of SARS-CoV-2 required host factors. J Infect. 2021; 84(3):418-467.
PMC: 8694781.
DOI: 10.1016/j.jinf.2021.12.011.
View
3.
Li C, Tang Z, Zhang W, Ye Z, Liu F
. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 2021; 49(W1):W242-W246.
PMC: 8262695.
DOI: 10.1093/nar/gkab418.
View
4.
Srinivasula S, Poyet J, Razmara M, Datta P, Zhang Z, Alnemri E
. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem. 2002; 277(24):21119-22.
DOI: 10.1074/jbc.C200179200.
View
5.
Mohseni Afshar Z, Dayani M, Naderi M, Ghanbarveisi F, Shiri S, Rajati F
. Fatality rate of COVID-19 in patients with malignancies: a sytematic review and meta-analysis. J Infect. 2020; 81(2):e114-e116.
PMC: 7255731.
DOI: 10.1016/j.jinf.2020.05.062.
View